The hepoxilin stable analogue, PBT-3, inhibits primary, platelet-related hemostasis in whole blood measured in vitro with the PFA-100
- 1 January 2003
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 112 (4) , 245-248
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hepoxilin Analogs Inhibit Bleomycin-Induced Pulmonary Fibrosis in the MouseThe Journal of Pharmacology and Experimental Therapeutics, 2002
- A New Family of Thromboxane Receptor Antagonists with Secondary Thromboxane Synthase InhibitionThe Journal of Pharmacology and Experimental Therapeutics, 2002
- The hepoxilin analog PBT-3 inhibits heparin-activated platelet aggregation evoked by ADP.FEBS Letters, 2002
- The Hepoxilins1999
- The Platelet Function Analyzer (PFA‐100®): a novel in‐vitro system for evaluation of primary haemostasis in childrenBritish Journal of Haematology, 1998
- Characterization of an In Vitro Platelet Function Analyzer, PFA-100™Clinical and Applied Thrombosis/Hemostasis, 1996
- Description of an In Vitro Platelet Function Analyzer-PFA-100™Seminars in Thrombosis and Hemostasis, 1995
- Hepoxilins: A review on their enzymatic formation, metabolism and chemical synthesisLipids, 1995
- Hepoxilins: a review on their cellular actionsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Synthesis of racemic 11,12-cyclopropyl analogs of hepoxilins A3 and B3Tetrahedron Letters, 1993